Thursday, July 3, 2025

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics approval. The study is being conducted in connection with the development of iSTRYM, the firms digital therapeutics platform.

The ethics approval, which comes from Veritas IRB, effectively ensures that processes included in research studies respects participants rights and that they are delivered utilizing the highest standards of ethical practice in human studies. The approval effectively signifies the scientific validation of the study.

The study is being conducted to inform the development of iSTRYM, and how it is built out to best serve therapists, patients, and the psychedelics industry as a whole.

“As we build out iSTRYM to be the largest data repository of psychedelic experiences, we are ensuring that its development is rooted in research proof and a deep understanding of the systems and protocols provided during psychedelic therapy.”

Kelsey Ramsden, CEO of Mind Cure Health

Mind Cure Health last traded at $0.55 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Mind Cure Set To Launch Products Into Psychedelic Therapy Adaptogen Supplement Category

Mind Cure Health (CSE: MCUR) has completed the development of its first products. The company...

Tuesday, January 26, 2021, 08:43:59 AM

Mind Cure Launches Product Sales Division

Mind Cure Health (CSE: MCUR) continued its constant roll of news this week, announcing this...

Thursday, February 18, 2021, 07:19:26 AM

Mind Cure Appoints Kelsey Ramsden As CEO And President

Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey...

Tuesday, December 1, 2020, 08:51:06 AM

Mind Cure Sees Warrants Approved For Trading

Mind Cure Health (CSE: MCUR) is looking to provide a boost to its liquidity for...

Thursday, February 11, 2021, 09:32:23 AM

Mind Cure Health Appoints Rob Hill To Board Of Directors

Mind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the...

Monday, February 22, 2021, 09:12:53 AM